Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2999841000168116 | Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2999851000168119 | Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | Is a | Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | has container type | vial | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | has TP | Citanest | true | Inferred relationship | Some | ||
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | has TPUU | Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR